Venom from deadly Asian snake may help develop painkillers

Image
Press Trust of India Melbourne
Last Updated : Oct 31 2016 | 2:48 PM IST
Venom derived from the long-glanded blue coral snake - one of Southeast Asia's rarest and deadliest snakes - may help develop better painkiller that could help manage pain without the side effect of addiction.
The snake with electric blue stripes and neon-red head and tail grows up to two metres long. Its venom glands extend to 60 centimetres - about a quarter of its body length.
Described as "the killer of killers" due to its taste for young king cobras, this snake is unique among snakes because, like scorpions, its venom causes its prey to spasm.
"This venom hits a particular type of sodium channel that is important for the treatment of pain in humans," said Bryan Fry, from the University of Queensland in Australia.
Researchers identified six unusual peptides in the venom of the blue coral snake that can switch on all of its prey's nerves at once. This immediately immobilises its victim.
The found that the venom used receptors which were critical to pain in humans. Learning how these work may enable improved pain treatment and management, the 'Sydney Morning Herald' reported.
"It's a great example of why studying the really weird animals is a great path for biodiscovery and you can't get any weirder than this snake with the longest venom glands in the world," Fry said.
The findings were published in the journal Toxins.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 31 2016 | 2:48 PM IST

Next Story